ORIGINAL RESEARCH
Published on 23 Sep 2025
Cost-effectiveness analysis of lurbinectedin plus atezolizumab as first-line treatment for extensive-stage small-cell lung cancer
doi 10.3389/fimmu.2025.1658740
- 877 views
- Frontiers in Immunology
- Cancer Immunity and Immunotherapy
- Research Topics
- Novel anti-cancer drugs combination radio-immunotherapy strategy: new frontiers in cancer immunotherapy
Novel anti-cancer drugs combination radio-immunotherapy strategy: new frontiers in cancer immunotherapy
2,669
Total downloads
12k
Total views and downloads
Articles
CASE REPORT
Published on 11 Sep 2025
Long-term complete remission with immunotherapy in advanced RET fusion-positive NSCLC with brain metastases: a case report and literature review
doi 10.3389/fonc.2025.1597110
- 812 views
STUDY PROTOCOL
Published on 08 Aug 2025
Total neoadjuvant chemoradiotherapy plus anti PD-1 for mid-to-low locally advanced rectal cancer: study protocol of a prospective, single arm, phase II study (STARS - RC06)
doi 10.3389/fonc.2025.1594927
- 1,139 views
MINI REVIEW
Published on 04 Jul 2025
Immuno-protective impact and clinical translation of radioprotective agents in cancer radiotherapy
doi 10.3389/fimmu.2025.1610296
- 1,270 views
ORIGINAL RESEARCH
Published on 23 Jun 2025
BRICS sequential therapeutic regimen as first-Line treatment for PD-L1-negative metastatic non-small cell lung cancer patients harboring EGFR/ALK wild-type status: a retrospective study
doi 10.3389/fimmu.2025.1618110
- 1,761 views
- 1 citation
MINI REVIEW
Published on 13 May 2025
Ultrasound-assisted immunotherapy for malignant tumour
doi 10.3389/fimmu.2025.1547594
- 1,766 views
ORIGINAL RESEARCH
Published on 08 May 2025
Combined stereotactic radiation therapy and immunotherapy for metastatic uveal melanoma
doi 10.3389/fonc.2025.1567504
- 1,389 views
- 1 citation
Published in
Frontiers in Immunology
Cancer Immunity and Immunotherapy
Participating Journals
Frontiers in Oncology
- 3.3 impact factor
- 6.9 citescore